Article info

Download PDFPDF
Original research
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

Authors

  1. Correspondence to Dr Anneke van der Walt; anneke.vanderwalt{at}monash.edu
View Full Text

Citation

Foong YC, Merlo D, Gresle M on behalf of MSBASE study group, et al
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

Publication history

  • Received October 27, 2023
  • Accepted February 11, 2024
  • First published March 7, 2024.
Online issue publication 
July 15, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.